There appears a plausible mechanism for Thymoquinone to be effective in treating/preventing COVID-19, and indeed as early as July 2020, it was stated that
"Therefore, the time is probably appropriate to move thymoquinone from experimentation on the bench to clinical testing for the Covid‐19
pandemic."
- Ahmad A, Rehman MU, Ahmad P, Alkharfy KM. Covid‐19 and thymoquinone:
Connecting the dots. Phytotherapy Research. 2020 Jun 26.
Numerous authors find the potential across numerous studies, including your study and the two below.
- Xu, H., Liu, B., Xiao, Z., Zhou, M., Ge, L., Jia, F., ... & Wang, G.
(2021). Computational and experimental studies reveal that
thymoquinone blocks the entry of coronaviruses into in vitro cells.
Infectious diseases and therapy, 10(1), 483-494
- Badary, Osama A., Marwa S. Hamza, and Rajiv Tikamdas. "Thymoquinone: A Promising
Natural Compound with Potential Benefits for COVID-19 Prevention and
Cure." Drug Design, Development and Therapy 15 (2021): 1819.
The best answer I can offer is yes it is possible that Thymoquinone may potentially be a treatment for COVID-19 (a cure is a little too strong), but I can find no evidence Thymoquinone has progressed to later-phase clinical trials, so we may never be able to answer this question. The lack of advancement of a potential treatment to a later-phase clinical trial is common for many theorized treatments, even when treatment mechanisms are demonstrated. Later stage clinical trials are expensive, and only a few of the most likely candidates will make it to published and peer-reviewed later-phase clinical trials.